Company Profiles

driven by the PitchBook Platform

Aukera Therapeutics

Description

Developer of a protein therapy to treat a neurodegenerative disease. The company offers a protein therapy using a form of angiogenin, a naturally occurring protein that stimulates nerve growth to treat Lou Gehrigs disease.

2010

Founded

PRIVATE

Status

Seed

Latest Deal Type

1

Investors

Description

Developer of a protein therapy to treat a neurodegenerative disease. The company offers a protein therapy using a form of angiogenin, a naturally occurring protein that stimulates nerve growth to treat Lou Gehrigs disease.

Ownership Status

Privately Held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology
Biotechnology

Primary Office

117 Maple Street Belmont, MA 02478United States +1 (617) 489-5390
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Aukera Therapeutics's full profile, request a free trial.

    Aukera Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Aukera Therapeutics Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    MassChallengeAccelerator/IncubatorMinority000 0000000 0000
    MassChallenge Accelerator/Incubator
    Request full access to PitchBook